Risk Stratification of Patients with Chronic Myocardial Infarction

The present invention is directed to novel radiopharmaceuticals, which can be used to image myocardium. In addition, the present invention is directed to methods for risk stratification of patients who have suffered at least one myocardial infarction.

Saved in:
Bibliographic Details
Main Authors DYSZLEWSKI MARY, PIERRO JOSEPH, RAJAGOPALAN RAGHAVAN, CARRETTA ROBERT, PANDURANGI RAGHOOTTAMA
Format Patent
LanguageEnglish
Published 03.12.2009
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
DIAGNOSIS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SURGERY
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to novel radiopharmaceuticals, which can be used to image myocardium. In addition, the present invention is directed to methods for risk stratification of patients who have suffered at least one myocardial infarction.
Bibliography:Application Number: US20090476769